117 related articles for article (PubMed ID: 1682474)
21. Maleylated human serum albumin inhibits HIV-1 infection in vitro.
Takami M; Sone T; Mizumoto K; Kino K; Tsunoo H
Biochim Biophys Acta; 1992 Dec; 1180(2):180-6. PubMed ID: 1281431
[TBL] [Abstract][Full Text] [Related]
22. Effect of cacao husk extract on human immunodeficiency virus infection.
Unten S; Ushijima H; Shimizu H; Tsuchie H; Kitamura T; Moritome N; Sakagami H
Lett Appl Microbiol; 1991 Dec; 13(6):251-4. PubMed ID: 1367748
[TBL] [Abstract][Full Text] [Related]
23. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E
J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
[TBL] [Abstract][Full Text] [Related]
24. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
25. Decreased CD4 and wide-ranging expression of other immune receptors after HIV-envelope-mediated formation of syncytia in vitro.
Rivera-Toledo E; López-Balderas N; Huerta L; Lamoyi E; Larralde C
Arch Virol; 2010 Aug; 155(8):1205-16. PubMed ID: 20508956
[TBL] [Abstract][Full Text] [Related]
26. Replicative characteristics of primary isolates of the human immunodeficiency virus type 1 in peripheral blood mononuclear cells, primary macrophages and CD4+ transformed T-cell lines.
Jolly PE
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1057-65. PubMed ID: 9449539
[TBL] [Abstract][Full Text] [Related]
27. Isolation of CD4-independent primary human immunodeficiency virus type 1 isolates that are syncytium inducing and acutely cytopathic for CD8+ lymphocytes.
Zerhouni B; Nelson JA; Saha K
J Virol; 2004 Feb; 78(3):1243-55. PubMed ID: 14722279
[TBL] [Abstract][Full Text] [Related]
28. CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells.
Sekigawa I; Chamow SM; Groopman JE; Byrn RA
J Virol; 1990 Oct; 64(10):5194-8. PubMed ID: 2398542
[TBL] [Abstract][Full Text] [Related]
29. 3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.
Buckheit RW; Germany-Decker J; Qualls-Goodwin K; Bowdon BJ; Shannon WM
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8361-5. PubMed ID: 1355606
[TBL] [Abstract][Full Text] [Related]
30. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
Fukudome K; Furuse M; Imai T; Nishimura M; Takagi S; Hinuma Y; Yoshie O
J Virol; 1992 Mar; 66(3):1394-401. PubMed ID: 1738199
[TBL] [Abstract][Full Text] [Related]
31. Fusion activity dissociated from replication ability in feline immunodeficiency virus (FIV) in human cells.
Tochikura TS; Tanabe-Tochikura A; Hayes KA; Lazo A; Bailer RT; Blakeslee JR; Lafrado LJ; Roy-Burman P; Pandey R; Olsen RG
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1301-10. PubMed ID: 8254466
[TBL] [Abstract][Full Text] [Related]
32. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
LaBonte JA; Madani N; Sodroski J
J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
[TBL] [Abstract][Full Text] [Related]
33. The nef gene controls syncytium formation in primary human lymphocytes and macrophages infected by HIV type 1.
Meylan PR; Baumgartner M; Ciuffi A; Munoz M; Sahli R
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1531-42. PubMed ID: 9840286
[TBL] [Abstract][Full Text] [Related]
34. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus type 1 (HIV-1) superinfection of a cell clone converting it from production of defective to infectious HIV-1 is mediated predominantly by CD4 regions other than the major binding site for HIV-1 glycoproteins.
Ohki K; Kishi M; Ohmura K; Morikawa Y; Jones IM; Azuma I; Ikuta K
J Gen Virol; 1992 Jul; 73 ( Pt 7)():1761-72. PubMed ID: 1629701
[TBL] [Abstract][Full Text] [Related]
36. Fusion of uninfected T-cells occurs with immature HIV-1 protease-mutant, but not morphologically similar protease inhibitor derived particles.
Bahmani MK; Kameoka M; Goto T; Sano K; Luftig RB; Ikuta K
Virus Res; 2000 Feb; 66(2):131-7. PubMed ID: 10725546
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.
Genois N; Barbeau B; Olivier M; Tremblay MJ
Clin Exp Immunol; 2001 Apr; 124(1):32-42. PubMed ID: 11359440
[TBL] [Abstract][Full Text] [Related]
38. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.
Lazaro I; Naniche D; Signoret N; Bernard AM; Marguet D; Klatzmann D; Dragic T; Alizon M; Sattentau Q
J Virol; 1994 Oct; 68(10):6535-46. PubMed ID: 7916060
[TBL] [Abstract][Full Text] [Related]
39. LFA-1 adhesion molecules are not involved in the early stages of HIV-1 env-mediated cell membrane fusion.
Golding H; Dimitrov DS; Blumenthal R
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1593-8. PubMed ID: 1457205
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission.
Pantaleo G; Butini L; Graziosi C; Poli G; Schnittman SM; Greenhouse JJ; Gallin JI; Fauci AS
J Exp Med; 1991 Feb; 173(2):511-4. PubMed ID: 1671082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
